Viewing Study NCT00539968


Ignite Creation Date: 2025-12-24 @ 5:31 PM
Ignite Modification Date: 2026-03-26 @ 4:05 PM
Study NCT ID: NCT00539968
Status: TERMINATED
Last Update Posted: 2015-02-05
First Post: 2007-10-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
None Breast Cancer View
None Ovarian Cancer View
None Lung Cancer View
None Gastric Cancer View
Keywords: